Dong-E-E-Jiao Co.,Ltd. (SHE:000423)
52.28
+0.89 (1.73%)
Feb 3, 2026, 11:34 AM CST
Dong-E-E-Jiao Revenue
Dong-E-E-Jiao had revenue of 1.72B CNY in the quarter ending September 30, 2025, a decrease of -5.59%. This brings the company's revenue in the last twelve months to 6.12B, up 4.61% year-over-year. In the year 2024, Dong-E-E-Jiao had annual revenue of 5.92B with 25.57% growth.
Revenue (ttm)
6.12B
Revenue Growth
+4.61%
P/S Ratio
5.39
Revenue / Employee
1.49M
Employees
4,095
Market Cap
33.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.92B | 1.21B | 25.57% |
| Dec 31, 2023 | 4.72B | 673.45M | 16.66% |
| Jan 1, 2023 | 4.04B | 192.83M | 5.01% |
| Jan 1, 2022 | 3.85B | 439.55M | 12.89% |
| Dec 31, 2020 | 3.41B | 439.36M | 14.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Humanwell Healthcare (Group) | 24.18B |
| Beijing Tongrentang | 18.09B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Livzon Pharmaceutical Group | 11.85B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 5.37B |
| Kangmei Pharmaceutical | 5.28B |